2014
DOI: 10.1016/j.enzmictec.2014.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
60
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 79 publications
(61 citation statements)
references
References 58 publications
1
60
0
Order By: Relevance
“…VLPs have been utilized to encapsulate diverse materials, such as metallic nanoparticles, drugs,, DNA,, RNAs,, proteins and enzymes,,, to obtain new materials, nanoreactors and delivery systems.…”
Section: Resultsmentioning
confidence: 99%
“…VLPs have been utilized to encapsulate diverse materials, such as metallic nanoparticles, drugs,, DNA,, RNAs,, proteins and enzymes,,, to obtain new materials, nanoreactors and delivery systems.…”
Section: Resultsmentioning
confidence: 99%
“…This conversion is often inefficient and occurs in healthy tissues away from the tumor, resulting in off target cytotoxicity (Moen et al, 2012). To address this issue CCMV ePVNs were used to encapsulate via electrostatic interactions a soluble version of a bacterial CYP (Sanchez-Sanchez et al, 2014). CCMV encapsulated CYP readily converted Resveratrol and tamoxifen prodrug formulations to their active forms and at levels comparable or greater than observed in human liver microsomal preparations.…”
Section: Nanoreactors For Enzymatic and Therapeutic Conversionmentioning
confidence: 99%
“…This is accomplished through denaturation of the cage structure and reassembling it in the presence of cargos [28,53]. In many cases the specificity and loading efficiency can be increased through the use of electrostatics [21,25,38,5456]. Unfortunately, complete modification of each core monomer with internal cargos often interferes with VLP assembly, and a more successful approach for cargo loading was achieved by in vitro mixing of genetically modified and unmodified core monomers [16].…”
Section: Cargo Encapsulationmentioning
confidence: 99%